(Q51771337)

English

RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation

scientific article published on 12 March 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19282830

RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19282830

chronic myeloid leukemia

0 references

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

chronic myelomonocytic leukemia

1 reference

based on heuristic

inferred from title

author name string

M-C Kuo

1

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19282830

D-C Liang

2

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19282830

C-F Huang

3

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19282830

Y-S Shih

4

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19282830

J-H Wu

5

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19282830

T-L Lin

6

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19282830

L-Y Shih

7

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19282830

publication date

12 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19282830

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19282830

23

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19282830

8

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19282830

1426-1431

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19282830

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

Tyrosine kinase fusion genes in chronic myeloproliferative diseases.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

Core-binding factors in haematopoiesis and leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

Novel loss-of-function mutations of the haematopoiesis-related transcription factor, acute myeloid leukaemia 1/runt-related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

Crystal structure of a thermostable type B DNA polymerase from Thermococcus gorgonarius

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

Genetics of myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

21 January 2018

M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatic point mutations in RUNX1/CBFA2/AML1 are common in high-risk myelodysplastic syndrome, but not in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

7 January 2021

based on heuristic

inferred from DOI database lookup

Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

7 January 2021

based on heuristic

inferred from DOI database lookup

Trisomy 13 is strongly associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.48

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2009.48

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19282830

release_bk72qxff3ffzlla34lotgmkhy4

1 reference

https://api.fatcat.wiki/v0/release/bk72qxff3ffzlla34lotgmkhy4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19282830

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51771337&oldid=2282275275"